Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
10/2009
10/29/2009US20090270409 Compounds and compositions as modulators of gpr119 activity
10/29/2009US20090270408 Amide derivatives as positive allosteric modulators and methods of use thereof
10/29/2009US20090270399 Novel pyridazine derivatives and medicines containing the same as effective ingredients
10/29/2009US20090270393 Iminopyridine Derivatives and Use Thereof
10/29/2009US20090270391 THIENOPYRIDINE DERIVATIVE, OR QUINOLINE DERIVATIVE, OR QUINAZOLINE DERIVATIVE, HAVING c-MET AUTOPHOSPHORYLATION INHIBITING POTENCY
10/29/2009US20090270374 Derivatives and analogs of n-ethylquinolones and n-ethylazaquinolones
10/29/2009US20090270372 Melanocortin receptor MC4 modulators; obesity, sexual disorders, anxiolytic agents, analgesics, antidepressants; 6-(aminomethyl)-2-aminobenzimidazole derivatives
10/29/2009US20090270371 Quinoline derivatives useful in the treatment of mglur5 receptor-mediated disorders
10/29/2009US20090270367 Substituted hydroxyethylamine aspartyl protease inhibitors
10/29/2009US20090270366 Benzoimidazole compounds
10/29/2009US20090270365 such as N-(2,4-dimethyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)-2-(piperidin-1-ylmethyl)biphenyl-4-carboxamide, having vanilloid receptor 1 antagonistic activity, used as analgesics
10/29/2009US20090270361 Substituted pyrazole derivatives and use thereof
10/29/2009US20090270360 Dicarboxamide derivatives
10/29/2009US20090270355 Compounds
10/29/2009US20090270350 Pyridinone Pyrazole Urea and Pyrimidinone Pyrazole Urea Derivatives
10/29/2009US20090270338 Diaryl-cyclylalkyl derivatives as calcium channel blockers
10/29/2009US20090270336 Piperazine derivatives
10/29/2009US20090269541 Optical recording material, chalcone type compounds and metal complexes
10/29/2009US20090269301 Novel Inhibitors of Glutaminyl Cyclase
10/29/2009US20090269300 Anthranilamides for Controlling Invertebrate Pests
10/29/2009CA2753532A1 Nicotinamide derivatives
10/29/2009CA2723185A1 Inhibitors of protein kinases
10/29/2009CA2722345A1 1-aryl-3-aminoalkoxy pyrazoles as sigma ligands enhancing analgesic effect of opioids and attenuating the dependency thereof
10/29/2009CA2722340A1 Small-molecule inhibitors of the androgen receptor
10/29/2009CA2722288A1 1,5-diphenyl-pyrrolidin-2-one compounds as cb-1 ligands
10/29/2009CA2722256A1 5-methyl-1-(naphthalen-2-yl)-1h-pyrazoles useful as sigma receptor inhibitors
10/29/2009CA2722159A1 Substituted phenylimidazole compounds and their use as ido inhibitors
10/29/2009CA2722139A1 Carboxamide compounds for the treatment of metabolic disorders
10/29/2009CA2722075A1 Long-chain fatty acyl elongase inhibitor comprising arylsulfonyl derivative as active ingredient
10/29/2009CA2722035A1 Quinoline or isoquinoline substituted p2x7 antagonists
10/29/2009CA2722028A1 5-hydroxypyrimidine-4-carboxamide compound
10/29/2009CA2721944A1 Pyrrole antifungal agents
10/29/2009CA2721908A1 (5r)-1,5-diaryl-4,5-dihydro-1h-pyrazole-3-carboxamidine derivatives having cb1-antagonistic activity
10/29/2009CA2721750A1 Carbamate and urea inhibitors of 11beta-hydroxysteroid dehydrogenase 1
10/29/2009CA2721576A1 Compound having npy y5 receptor antagonist activity
10/29/2009CA2721260A1 Isoquinolinone derivatives as nk3 antagonists
10/29/2009CA2720818A1 Substituted phenoxybenzamides
10/29/2009CA2720654A1 Novel substituted heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
10/29/2009CA2719936A1 Substituted pyrimidin-5-carboxamides 281
10/28/2009EP2112228A1 Method for detecting pathogenic microorganism and antimicrobial agent, method for evaluating effect of antimicrobial agent, and antimicrobial agent
10/28/2009EP2111402A2 Aminopyrazole kinase inhibitors
10/28/2009EP2111401A1 4-{4-[({3-tert-butyl-1-[3-(hydroxymethyl) phenyl]-1h-pyrazol-5-yl } carbamoyl)-amino]-3-fluorophenoxy} -n-methylpyridine-2-carboxamide as well as prodrugs and salts thereof for the treatment of cancer
10/28/2009EP2111400A1 Pyridine compounds and their use as p2y12 antagonists.
10/28/2009EP2111396A1 Hcv inhibiting macrocyclic phenylcarbamates
10/28/2009EP2111395A1 New phenyl- (4-phenyl-pyrimidin-2-yl) - amines derivatives, preparation thereof as drugs, pharmaceutical compositions and use thereof essentially as ikk inhibitors
10/28/2009EP1633717B1 P2x7 receptor antagonists and their use
10/28/2009EP1631548B1 Inhibitors of akt activity
10/28/2009EP1379504B1 Bipiperidinyl-derivatives and their use as chemokine receptors inhibitors
10/28/2009CN101568534A Benzoyl amino heterocyclyl compounds useful in the treatment of a disease mediated through GLK
10/28/2009CN101568533A 3-heteroaryl (amino or amido)-1- (biphenyl or phenylthiazolyl) carbonylpiperdine derivatives as orexin receptor inhibitors
10/28/2009CN101568532A Cyclic derivatives as modulators of chemokine receptor activity
10/28/2009CN101568531A Polymorphs of a mglur5 receptor antagonist
10/28/2009CN101568530A Indol-4-yl-pyrimidinyl-2-yl-amine derivatives and use thereof as cyclin dependant kinase inhibitors
10/28/2009CN101568529A Heteroaryl-heteroaryl compounds as cdk inhibitors for the treatment of cancer, inflammation and viral infections
10/28/2009CN101568525A Cb1 receptor modulators
10/28/2009CN101568523A Novel intermediate and process useful in the preparation of {2-[1-(3,5-bis-trifluoromethyl-benzyl)-5-pyridin-4-yl-1H-[1,2,3]triazol-4-yl]-pyridin-3-yl}-(2-chlorophenyl)-methanone
10/28/2009CN101567425A Organic electroluminescence device, novel platinum complex compound and novel compound capable of being a ligand thereof
10/28/2009CN101565417A Benzenesulfonyl carboxamide and preparation method thereof
10/28/2009CN101565402A Indeno isoquinolone compound and preparation method and medical application thereof
10/28/2009CN101564390A Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of myelodysplastic syndromes
10/27/2009US7608731 Phenylacetic acid compounds
10/27/2009US7608718 4,5-dihydro-1H-pyrazole derivatives having potent CB1-antagonistic activity
10/27/2009US7608634 Substituted pyrrolines as kinase inhibitors
10/27/2009US7608629 Useful for the treatment of migraine and other 5-HT1F receptor associated disorders; for example, N-[3-(1-methyl-piperidin-4-yloxy)-phenyl]-2-furancarboxamide
10/27/2009US7608625 Method for treating bruxism and bruxism-related diseases
10/27/2009US7608621 Such as n-{[2-[(4-bromo-2-fluorophenyl)methyl]-5-hydroxy-6-(1-methylethyl)-3-oxo-2,3-dihydro-4-pyridazinyl]carbonyl}glycine; anemia; increasing erythropoietin production
10/27/2009US7608618 1-(2,2,2-trifluoroethanoyl)pyrrolidine-2-carboxylic acid [4-methoxy-3-(3-pyrazin-2-yl-ureido)phenyl]-amide; 4-Methoxy-N-(3-methylamino-propyl)-3-(3-pyrazin-2-yl-ureido)-benzamide; checkpoint kinase Chk1 inhibitor; chemosensitizing agents useful in the treatment of diseases related to DNA damage
10/27/2009US7608617 N,N-alkylene-6-(piperidin-1-ylalkoxy)naphthalene-2-carboxamide derivatives, e.g., piperidin-1-yl-[6-(3-piperidin-1-yl-propoxy)-naphthalen-2-yl]-methanone and 3,4-dihydro-1H-isoquinolin-2-yl)-[6-(3-piperidin-1-yl-propoxy)-naphthalen-2-yl]-methanone; especially for treating obesity
10/27/2009US7608590 19-(7-Methoxy-2-phenyl-quinolin-4-yloxy)-2, 16-dioxo-3,15,17-triaza-tricyclo[15.3.0.0*4,6*]icos-7-ene-4,14-dicarboxylic acid 4-ethyl ester 14-methyl ester, for example; inhibits the NS3 protease of flavivirus such as hepatitis C virus (HCV)
10/27/2009US7608563 3-phenoxy-4-pyridazinol derivatives and herbicide composition containing the same
10/27/2009CA2567935C Aminopyridine derivatives as selective dopamine d3 agonists
10/27/2009CA2536870C Phenyl or pyridyl amide compounds as prostaglandin e2 antagonists
10/27/2009CA2432713C Aniline derivatives or salts thereof and cytokine production inhibitors containing the same
10/27/2009CA2422210C Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
10/27/2009CA2421826C Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
10/27/2009CA2419665C Novel 2-phenylpiperazine derivatives
10/27/2009CA2381885C Isomeric fused pyrrolocarbazoles and isoindolones
10/27/2009CA2379021C New phenylpiperazines
10/27/2009CA2376355C N-heterocyclic derivatives as nos inhibitors
10/27/2009CA2361174C 4-amino-quinazoline and quinoline derivatives having an inhibitory effect on signal transduction mediated by tyrosine kinases
10/27/2009CA2243474C Quinolin-2-(1h)-ones
10/22/2009WO2009129508A1 Soluble epoxide hydrolase inhibitors
10/22/2009WO2009129036A1 Substituted cyclopropyl compounds, compositions containing such compounds and methods of treatment
10/22/2009WO2009128947A1 Piperazine derivatives
10/22/2009WO2009128512A1 Method for producing pyrimidine compound
10/22/2009WO2009128481A1 Nitrogenated 5-membered heterocyclic compound
10/22/2009WO2009128408A1 Process for producing an anthranilamide compound
10/22/2009WO2009128262A1 Quinolone derivative and use thereof
10/22/2009WO2009127949A1 4- [3- (aryloxy) benzylidene] -3-methyl piperidine aryl carboxamide compounds useful as faah inhibitors
10/22/2009WO2009127948A1 4- [3- (aryloxy) benzylidene] -3-methyl piperidine 5-membered aryl carboxamide compounds useful as faah inhibitors
10/22/2009WO2009127946A1 4-benzylidene-3-methylpiperidine aryl carboxamide compounds useful as faah inhibitors
10/22/2009WO2009127944A1 Ether benzylidene piperidine aryl carboxamide compounds useful as faah inhibitors
10/22/2009WO2009127943A1 Ether benzylidene piperidine 5-membered aryl carboxamide compounds useful as faah inhibitors
10/22/2009WO2009127686A1 Novel estrogen receptor ligands
10/22/2009WO2009127679A1 Indoles as modulators of nicoticic acetylcholine receptor subtype alpha-7
10/22/2009WO2009127678A1 Indoles as modulators of nicotinic acetylcholin receptor subtype alpha-71
10/22/2009WO2009127546A1 Pyrrolidinone glucokinase activators
10/22/2009WO2009127544A1 Pyridazinone glucokinase activators
10/22/2009WO2009127417A1 Quinoline derivatives as axl kinase inhibitors
10/22/2009WO2009127320A1 Tertiary amine derivatives as phosphodiesterase-4 inhibitors
1 ... 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 ... 1080